comprehensive -WSS

comprehensive

author：Wikipedia 2025-08-17 00:02:29 - browse：2

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Living with Fabry disease, a condition that causes chronic pain

WSS

NIH fellows want a pay raise. Will that mean less money for grants?

Study: Pain burden is higher in Black NFL players than white ones

The high cost of giving birth even with insurance

Sports medicine is finally prioritizing gender equality

Why 40% Americans with Parkinson’s don’t see a neurologist

Trump demands the U.S. pay no more for drugs than other countries … again

focus

comprehensive

entertainment

Alkermes shareholders re

Novavax promises a turnaround & Lilly roils the obesity market

Supreme Court strikes down use of affirmative action

At least 13 dead in Texas as scorching temps continue

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why 40% Americans with Parkinson’s don’t see a neurologist

In Memoriam: Notable people who died in 2023

NIH fellows want a pay raise. Will that mean less money for grants?

Peter Hotez and the public health issue of online harassment

Peter Hotez and the public health issue of online harassment

hotspot

Biden launches a new push to limit health care costs

Palantir health business leans on meeting customers’ needs

Study: Pain burden is higher in Black NFL players than white ones

Trump demands the U.S. pay no more for drugs than other countries … again

Heart attack and stroke risk calculators need revising

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

entertainment

focus

explore

knowledge